Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S O'Reilly

Showing results (31-40 of 291) with videos related to

Pageof 30
Sort By:
Nature|November 26, 2010
New oral chelating agent for treatment of Wilson's diseaseS O'Reilly, W Bank
Annals of the Rheumatic Diseases|February 1, 1995
Missed opportunity following diagnosis of goutS O'Reilly, M Doherty
Clinical and Experimental Immunology|November 16, 2018
The immunopathogenesis of fibrosis in systemic sclerosisM Brown, S O'Reilly
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
Is surgery necessary with multimodality treatment of oesophageal cancerS O'Reilly, A A Forastiere
Biological Research|January 1, 1994
Determination of the pKa of ionizable enzyme groups by nonlinear regression using a second degree equationS O'Reilly, M C Riveros
Irish Medical Journal|September 1, 1992
Palpating enlarged kidneysS O'Reilly, J A Keogh
Clinical and Experimental Immunology|August 13, 2020
B(effector)reaking bad in systemic sclerosis: role of a novel B cell subsetS O'Reilly, J van Laar
Hematology/Oncology Clinics of North America|August 1, 1997
Experimental chemotherapeutic agents for the treatment of colorectal carcinomaS O'Reilly, E K Rowinsky
Critical Reviews in Oncology/Hematology|September 1, 1996
The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996S O'Reilly, E K Rowinsky
Annals of Clinical Biochemistry|October 12, 2000
Thyroid function tests in acutely ill patientsE Bell, D S O'Reilly
Pageof 30

Showing results (31-40 of 291) with videos related to

Sort By:
Pageof 30
Nature|November 26, 2010
New oral chelating agent for treatment of Wilson's diseaseS O'Reilly, W Bank
Annals of the Rheumatic Diseases|February 1, 1995
Missed opportunity following diagnosis of goutS O'Reilly, M Doherty
Clinical and Experimental Immunology|November 16, 2018
The immunopathogenesis of fibrosis in systemic sclerosisM Brown, S O'Reilly
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
Is surgery necessary with multimodality treatment of oesophageal cancerS O'Reilly, A A Forastiere
Biological Research|January 1, 1994
Determination of the pKa of ionizable enzyme groups by nonlinear regression using a second degree equationS O'Reilly, M C Riveros
Irish Medical Journal|September 1, 1992
Palpating enlarged kidneysS O'Reilly, J A Keogh
Clinical and Experimental Immunology|August 13, 2020
B(effector)reaking bad in systemic sclerosis: role of a novel B cell subsetS O'Reilly, J van Laar
Hematology/Oncology Clinics of North America|August 1, 1997
Experimental chemotherapeutic agents for the treatment of colorectal carcinomaS O'Reilly, E K Rowinsky
Critical Reviews in Oncology/Hematology|September 1, 1996
The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996S O'Reilly, E K Rowinsky
Annals of Clinical Biochemistry|October 12, 2000
Thyroid function tests in acutely ill patientsE Bell, D S O'Reilly
Pageof 30